2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of …
FM Kusumoto, MH Schoenfeld, C Barrett… - Journal of the American …, 2019 - jacc.org
The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …
initial extensive evidence review, which included literature derived from research involving …
Electrical resynchronization and clinical outcomes during long-term follow-up in intraventricular conduction delay patients applied left bundle branch pacing-optimized …
X Chen, X Li, Y Bai, J Wang, S Qin, J Bai… - Circulation …, 2023 - Am Heart Assoc
BACKGROUND: Left bundle branch-optimized cardiac resynchronization therapy (LOT-
CRT) has shown encouraging results for QRS duration reduction and heart function …
CRT) has shown encouraging results for QRS duration reduction and heart function …
Incidental abnormal ECG findings and long-term cardiovascular morbidity and all-cause mortality: A population based prospective study
Background The additional prognostic value of resting electrocardiogram (ECG) in long-term
cardiovascular disease (CVD)-risk-assessment is unclear. We evaluated the association of …
cardiovascular disease (CVD)-risk-assessment is unclear. We evaluated the association of …
Investigating the link between ischemic heart disease and Behcet's disease: A cross-sectional analysis
Background Behcet's disease (BD) is a multi-systemic chronic inflammatory disorder which
involves the vasculature tree of all sizes. The current study's aim was to examine the …
involves the vasculature tree of all sizes. The current study's aim was to examine the …
Cardiac resynchronization therapy for patients with heart failure and nonspecific intraventricular conduction delay
Z Cao, X Chen, L Su, X Hou - Pacing and Clinical …, 2023 - Wiley Online Library
The efficacy of cardiac resynchronization therapy (CRT) in heart failure patients with left
bundle branch block (LBBB) is well established with Class I or IIa recommendation …
bundle branch block (LBBB) is well established with Class I or IIa recommendation …
Stroke among rheumatoid arthritis patients: does age matter? A real-life study
Abstract Background/Aims: Rheumatoid arthritis (RA) is a chronic, debilitating autoimmune
disease that affects the joints and it is known to be associated with cardiovascular morbidity …
disease that affects the joints and it is known to be associated with cardiovascular morbidity …
Prevalence and Clinical Significance of Intraventricular Conduction Disturbances in Hospitalized Children
C Cirillo, E Monda, R Esposito, D Colonna… - Journal of …, 2024 - mdpi.com
Introduction: Data on the prevalence and clinical significance of interventricular conduction
disturbances (IVCDs) in children are scarce. While incomplete right bundle branch blocks …
disturbances (IVCDs) in children are scarce. While incomplete right bundle branch blocks …
Nonspecific intraventricular conduction delay is associated with future occurrence of atrial fibrillation in patients with structurally normal heart
Background We aimed to elucidate the long-term prognosis of nonspecific intraventricular
conduction delay (NIVCD) in patients with structurally normal heart. Methods We included …
conduction delay (NIVCD) in patients with structurally normal heart. Methods We included …
Non-specific intraventricular conduction delay and ventricular pre-excitation:“Pseudo-P wave”, warning for it!
A Parlavecchio, G Vetta, R Caminiti… - Journal of …, 2022 - Elsevier
Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults with substantial
morbidity and mortality. The diagnosis of AF is established by electrocardiogram showing …
morbidity and mortality. The diagnosis of AF is established by electrocardiogram showing …
[引用][C] Acute intraventricular conduction disorder due to combination therapy with dabrafenib and trametinib for metastatic melanoma: Case report.
K Yamamura, S Matsushita, M Aoki… - The Journal of …, 2017 - europepmc.org
GlaxoSmithKline A Phase III, randomised, open-label study comparing the combination of
the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib to the BRAF inhibitor …
the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib to the BRAF inhibitor …